Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9175682 | 1.00 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL5173363 | 1.00 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL10765606 | 0.98 | LMNA (0.43) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL8601633 | 0.98 | LMNA (0.43) | LMNAMAPK1SRCCYP2D6CES2 | |
| Water SCHEMBL17513119 | 0.98 | LMNA (0.43) | LMNAMAPK1SRCCYP2D6CES2 | |
| Water SCHEMBL9138593 | 0.98 | LMNA (0.43) | LMNAMAPK1SRCCYP2D6CES2 | |
| Water SCHEMBL17513118 | 0.98 | LMNA (0.43) | LMNAMAPK1SRCCYP2D6CES2 | |
| Benzene SCHEMBL23120173 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL9036 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL21723253 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415473-B1 | ORAL CARE COMPOSITIONS CONTAINING COMBINATIONS OF ANTI-BACTERIAL AND HOST-RESPONSE MODULATING AGENTS | PROCTER & GAMBLE (US) | 2014-09-17 | — | — | EP | claimed |
| EP-0464059-A1 | METHOD OF DE-INKING WASTE PAPER MATERIALS. | BDL SPECIALIST PROD (GB) | 1992-01-08 | — | — | EP | claimed |
| WO-1990010749-A1 | METHOD OF DE-INKING WASTE PAPER MATERIALS | BDL SPECIALIST PRODUCTS LIMITED (GB) | 1990-09-20 | — | — | WO | claimed |
| EP-0219073-B1 | STABILIZATION OF INTERFERONS | F. HOFFMANN-LA ROCHE AG (CH) | 1990-03-07 | — | — | EP | claimed |
| EP-0306546-A1 | Irradiation produced AMPS/Am copolymers in thickened acid compositions | PHILLIPS PETROLEUM COMPANY (US) | 1989-03-15 | — | — | EP | claimed |
| EP-0264859-A2 | 2-(2-substituted benzoyl)-4-(substituted)-1,3-cyclohexanediones, a process for their production and a herbicidal composition containing them | STAUFFER CHEMICAL COMPANY (US) | 1988-04-27 | — | — | EP | claimed |
| EP-0264737-A2 | 2-(2-substituted benzoyl)-4-(substituted imino, oximino or carbonyl)-1,3-cyclo-hexanediones, a process for their production, and a herbicidal composition containing them | STAUFFER CHEMICAL COMPANY (US) | 1988-04-27 | — | — | EP | claimed |
| EP-0259285-A2 | Process for improving the eating and preservation qualities of uncured pork products | Geo. A. Hormel & Co. (US) | 1988-03-09 | — | — | EP | claimed |
| EP-0249149-A1 | Certain 3-benzoyl-4-oxolactams | STAUFFER CHEMICAL COMPANY (US) | 1987-12-16 | — | — | EP | claimed |
| EP-4189062-A1 | INDUSTRIAL FERMENTATION PROCESS FOR BACILLUS USING FEED RATE SHIFT | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-4189104-A1 | INDUSTRIAL FERMENTATION PROCESS FOR BACILLUS USING PARTIAL HARVEST | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-4189103-A1 | INDUSTRIAL FERMENTATION PROCESS FOR BACILLUS USING TEMPERATURE SHIFT | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023097309-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISCERAL PAIN | IRONWOOD PHARMACEUTICALS, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| US-11639937-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2023-05-02 | — | — | US | disclosed |
| EP-0237150-A2 | Improved radionuclide antibody coupling | NEORX CORPORATION (US) | 1987-09-16 | — | — | EP | disclosed |
| EP-0236059-A2 | Preparation of erythropoietin-producing cells and production process of erythropoietin using same | SNOW BRAND MILK PRODUCTS CO. LTD. (JP) | 1987-09-09 | — | — | EP | disclosed |
| EP-0234599-A1 | Cysteine-depleted muteins of interleukin-2, their preparation, formulations containing them, and genes, vectors and organisms suitable for use in the preparation of said muteins | CETUS ONCOLOGY CORPORATION (US) | 1987-09-02 | — | — | EP | disclosed |
| EP-0234938-A2 | Application of tetrathiafulvalenes in bioelectrochemical processes | CRANFIELD BIOTECHNOLOGY LTD (GB) | 1987-09-02 | — | — | EP | disclosed |
| WO-1987004726-A1 | PROCESS FOR PURIFYING RECOMBINANT PROTEINS, AND PRODUCTS THEREOF | CAMBRIDGE BIOSCIENCE CORPORATION (US) | 1987-08-13 | — | — | WO | disclosed |
| EP-0229016-A2 | Interleukin-2 compositions | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1987-07-15 | — | — | EP | disclosed |